NM_005005.3:c.101+39C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005005.3(NDUFB9):c.101+39C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 1,605,236 control chromosomes in the GnomAD database, including 63,743 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 5729 hom., cov: 32)
Exomes 𝑓: 0.28 ( 58014 hom. )
Consequence
NDUFB9
NM_005005.3 intron
NM_005005.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.851
Publications
12 publications found
Genes affected
NDUFB9 (HGNC:7704): (NADH:ubiquinone oxidoreductase subunit B9) The protein encoded by this gene is a subunit of the mitochondrial oxidative phosphorylation complex I (nicotinamide adenine dinucleotide: ubiquinone oxidoreductase). Complex I is localized to the inner mitochondrial membrane and functions to dehydrogenate nicotinamide adenine dinucleotide and to shuttle electrons to coenzyme Q. Complex I deficiency is the most common defect found in oxidative phosphorylation disorders and results in a range of conditions, including lethal neonatal disease, hypertrophic cardiomyopathy, liver disease, and adult-onset neurodegenerative disorders. Pseudogenes of this gene are found on chromosomes five, seven and eight. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
TATDN1 (HGNC:24220): (TatD DNase domain containing 1) Predicted to enable 3'-5'-exodeoxyribonuclease activity. Predicted to be involved in DNA metabolic process and nucleic acid phosphodiester bond hydrolysis. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 8-124539326-C-T is Benign according to our data. Variant chr8-124539326-C-T is described in ClinVar as [Benign]. Clinvar id is 1291363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.426 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.268 AC: 40763AN: 151928Hom.: 5728 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40763
AN:
151928
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.283 AC: 69929AN: 246854 AF XY: 0.293 show subpopulations
GnomAD2 exomes
AF:
AC:
69929
AN:
246854
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.276 AC: 401141AN: 1453190Hom.: 58014 Cov.: 29 AF XY: 0.281 AC XY: 203233AN XY: 723434 show subpopulations
GnomAD4 exome
AF:
AC:
401141
AN:
1453190
Hom.:
Cov.:
29
AF XY:
AC XY:
203233
AN XY:
723434
show subpopulations
African (AFR)
AF:
AC:
9037
AN:
33334
American (AMR)
AF:
AC:
6230
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
AC:
7108
AN:
26080
East Asian (EAS)
AF:
AC:
16286
AN:
39626
South Asian (SAS)
AF:
AC:
37050
AN:
86058
European-Finnish (FIN)
AF:
AC:
18844
AN:
53216
Middle Eastern (MID)
AF:
AC:
1861
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
287431
AN:
1104398
Other (OTH)
AF:
AC:
17294
AN:
60048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
15651
31301
46952
62602
78253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.268 AC: 40763AN: 152046Hom.: 5729 Cov.: 32 AF XY: 0.276 AC XY: 20484AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
40763
AN:
152046
Hom.:
Cov.:
32
AF XY:
AC XY:
20484
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
11027
AN:
41488
American (AMR)
AF:
AC:
2721
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
956
AN:
3466
East Asian (EAS)
AF:
AC:
1904
AN:
5150
South Asian (SAS)
AF:
AC:
2128
AN:
4814
European-Finnish (FIN)
AF:
AC:
3769
AN:
10572
Middle Eastern (MID)
AF:
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17506
AN:
67954
Other (OTH)
AF:
AC:
533
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1536
3072
4607
6143
7679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1343
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.